Prophylactic contralateral neck dissection has no advantage in patients with early stage HPV-positive tonsil cancer

Acta Otolaryngol. 2022 Mar-Apr;142(3-4):345-349. doi: 10.1080/00016489.2022.2053200. Epub 2022 Apr 5.

Abstract

Background: Patients with locally advanced HPV-positive tonsil cancer would benefit from prophylactic contralateral neck dissection (pCND).

Aims/objectives: The aim of this study was to analyze rates of contralateral lymph node metastases (LNM) and their prognostic effects on locally advanced HPV-positive tonsillar squamous cell carcinoma.

Materials and methods: Medical records of 54 patients who underwent upfront primary surgery and pCND were retrospectively reviewed.

Results: Six (11.1%) patients had contralateral LNM in 54 locally advanced HPV-positive tonsil cancer. Of these, five patients had contralateral level II LNM and one patient had contralateral level II and III LNM. Contralateral LNM showed significant positive correlations with advanced T stage (p = .017) and the presence of extracapsular spread (p = .007). Contralateral lymph node metastasis had no significant association with five-year disease-specific survival.

Conclusions and significance: This study demonstrated no advantage in performing pCND in early stage HPV-positive tonsil cancer.

Keywords: Squamous cell carcinoma; lymphatic metastasis; papillomavirus infections; tonsillar neoplasms; tumor burden.

MeSH terms

  • Carcinoma, Squamous Cell*
  • Humans
  • Lymph Nodes / pathology
  • Lymphatic Metastasis
  • Neck Dissection
  • Neoplasm Staging
  • Papillomavirus Infections* / surgery
  • Retrospective Studies
  • Tonsillar Neoplasms* / pathology
  • Tonsillar Neoplasms* / surgery